Leading the Way in Russian Law
 


NEWS

more news

LEGAL UPDATES

more legal updates

PUBLICATIONS

more publications

RECENT DEALS

Advising American multinational media-company conglomerate Viacomon granting the right to use a group of trademarks of US TV channels and programs to Russian companies
more recent deals


  • Sergey Patrakeev,
    Partner

RSS  RSS Feed to Events

EVENTS

Highlights of the XXI Pharmaceutical Forum in Saint-Petersburg


On 19 – 21 of May St. Petersburg once again hosted the annual Pharmaceutical Forum organized by Adam Smith Institute. Lidings traditionally supported the most prominent event for the Russian life sciences sector as its premier partner.

Contrary to forecasts, the Forum yet again demonstrated exceptionally high attendance – this time the event brought together over five hundred representatives of the pharmaceuticals sector. Sergey Patrakeev, Partner and Co-Head of Healthcare and Pharmaceuticals industry practice at Lidings, chaired and moderated the session entitled “Legal Environment in 2015: Actions and Reactions”. Topics for discussion included “localization” of personal data,  innovative legal solutions that might be triggered by the new edition of Law “On Circulation of Drugs” and related governmental acts, risk management in the sphere of intellectual property, current macroeconomic realm and its effects of on M&A deals in Russia, and other topics high on the agenda.

The session brought together key experts in the field including Regulatory Affairs/Legal Director at AIPM Madina Plieva, Director - Legal and GR - at BIOCAD Galina Sekareva, Head of Legal and Compliance at Invar Anna Sologubova, Head of Legal Department at AstraZeneca Russia Irina Ivanischeva and Vice President (Legal) of STADA Group Christoph Dengler.

“As always, we notice active interest towards legal matters at the Russian Pharma Forum in St. Petersburg. This is not surprising considering the fact that the ever-changing situation on the market and in the applicable Russian legislation raises many new questions for the CEOs of the big pharmaceutical companies and their legal advisors. Among other things, we are noticing a growing number of requests related to dispute resolution, including IP disputes and debt collection proceedings. We believe that this trend will continue in the next few years, and since the development of the Russian legislation provides companies with new opportunities we see great prospects in the development of this practice”, comments Partner, Co-Head of Healthcare and Pharmaceuticals industry practice at Lidings Andrey Zelenin.

Adam Smith Pharmaceutical Forum is a major independent international event for the business community covering key aspects of the Russian pharmaceutical regulation. The initiative traditionally attracts manufacturers, distributors and retail chains, as well as leading experts and CEOs of the largest pharmaceutical enterprises who attend the event to discuss topics essential for the industry.

To download the Forum’s program and find out more about the speakers, please visit the official website.


back to Events   |   print page



TOP M&A
Legal Advisor
in Russia


Recommended in
All Key Practice Areas


Recommended Firm
for Dispute Resolution
in Russia


Best Life Sciences
Practice in Russia


Best Life Sciences practice,
recommended in corporate 

and M&A, dispute resolution 
in Russia


The Most Visible
Russian Law Firm


Recommended in
Key Practice Areas

Open Partnership: 
an inside look